Benjamin Paluch

Stock Analyst at Roth MKM

(1.28)

# 3,546

Out of 5,182 analysts

3

Total ratings

33.33%

Success rate

0.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$68.68	-5.36%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$2.42	+602.48%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$2.52	+296.83%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $68.68

Upside: -5.36%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $2.42

Upside: +602.48%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $2.52

Upside: +296.83%